×
Sign in
Menu
Home
Programmes
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
ESMO 2018 Congress
Final Programme PDF
Advanced Search
19.10.2018
20.10.2018
21.10.2018
22.10.2018
23.10.2018
Challenge Your Expert (CYE) session
EONS session
Educational session
Industry Satellite Symposium
Joint Symposium
Keynote lecture
Multidisciplinary interactive sessions
Patient Advocacy Track
Poster Discussion session
Poster Display session
Proffered Paper session
Special Symposium
Special session
Young Oncologist session
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
Hall A1 - Room 15
11:15(1h)
Different approaches and advances in the management of HPV+ patients
13:00(1h 30m)
Industry satellite symposium 45
18:30(1h 30m)
Industry satellite symposium 52
09:15(1h 30m)
Multiple myeloma
15:00(1h)
Optimal management of bone metastases in 2018
16:30(1h 30m)
State of the art management of GEP- NET
Hall A1 - Room 16
13:00(1h 30m)
Industry satellite symposium 46
18:30(1h 30m)
Industry satellite symposium 53
08:00(1h)
Optimal treatment of patients with metastatic colorectal cancer: Planned sequencing, or just taking the next best option?
14:45(1h 30m)
Proffered paper session - NETs and endocrine tumours
11:15(1h 05m)
Recurrent cervical cancer
Hall A1 - Room 17
08:15(45m)
Beyond resistance in immuno-oncology
11:15(1h 30m)
Changing landscape in renal and bladder cancer
14:45(1h 30m)
Early detection of cancer using minimally invasive biomarkers
09:15(1h 45m)
Proffered paper session- NSCLC, metastatic
Hall A2 - Room 18
16:30(1h 30m)
Presidential Symposium 3
09:15(1h 45m)
Proffered paper session - Gastrointestinal tumours, colorectal
11:15(1h 30m)
Proffered paper session - Immunotherapy of Cancer
14:45(1h 30m)
The force awakens: Immunotherapy in thoracic malignancies
Hall B3 - Room 20
09:30(1h)
At the heyday of molecular classification of cancer
11:00(1h 30m)
Global surveillance of cancer survival: Impact on cancer control
13:00(1h 30m)
Industry satellite symposium 47
18:30(1h 30m)
Industry satellite symposium 54
14:45(1h 15m)
Poster discussion - Basic science
08:00(1h)
Salivary gland cancers
Hall B3 - Room 21
08:00(1h)
Optimal management of luminal advanced breast cancer
09:30(1h 10m)
Poster Discussion session - Immunotherapy of cancer 2
16:30(1h)
Poster Discussion session - Supportive and palliative care 2
11:00(1h 30m)
The changing scenario of drug registration
14:45(1h 30m)
Undifferentiated sarcomas: From MFH to UPS with more distance still to travel
Hall B3 - Room 22
16:30(1h 30m)
Affordability and sustainability of new cancer drugs
13:00(1h 30m)
Industry satellite symposium 48
18:30(1h 30m)
Industry satellite symposium 55
11:00(1h 15m)
Poster Discussion session - NETs and endocrine tumours
14:45(1h 30m)
Proffered paper session - Public health policy
09:30(1h)
Tumour sequencing in drug development
08:00(1h)
What is the role of intratumour therapy?
Hall B3 - Room 23
08:00(1h)
Clinical application of liquid biopsy in metastatic lung cancer
13:00(1h 30m)
Industry satellite symposium - EONS 8
09:30(1h)
Managing early breast cancer during pregnancy
11:00(1h 15m)
Poster Discussion session - Sarcoma
15:00(1h)
The challenges of toxicities from endocrine treatment in men with prostate cancer
Hall B4 - Room 19
11:00(1h 30m)
Epigenetics
14:45(1h 30m)
ESMO-JSMO joint symposium: New predictive biomarkers in breast cancer therapeutics
13:00(1h 30m)
Industry satellite symposium 49
18:30(1h 30m)
Industry satellite symposium 56
ICM - Room 1
16:30(1h 30m)
Clinical implementation of PI3K inhibitors
13:00(1h 30m)
Industry satellite symposium 42
09:15(1h 30m)
Proffered paper session - Melanoma and other skin tumours
11:15(1h)
The paradigm of oligometastatic disease and ablative treatment
ICM - Room 13
14:45(1h 30m)
Drugging non-conventional targets
13:00(1h 30m)
Industry satellite symposium 44
18:30(1h 30m)
Industry satellite symposium 51
11:00(1h 30m)
Liquid biopsies in cancer management
09:15(1h 30m)
Minimising potentially futile treatments in advanced disease
ICM - Room 14a
08:00(1h)
Health care decision making and the international context
09:30(1h)
Neuroendocrine tumours: Role of theranostics and nuclear medicine
11:00(45m)
YO Brunch 3: Biosimilars: What they are and their use in oncology
14:15(1h 30m)
YO Fellowship Session: Fellowships in Europe: Educational opportunities for Young Oncologists
16:00(1h 30m)
YO Forum: Research projects: From ideas to papers
ICM - Room 14b
13:00(1h 30m)
Industry satellite symposium 43
18:30(1h 30m)
Industry satellite symposium 50
14:45(1h 30m)
Proffered paper session - Head and neck cancer
09:15(1h 30m)
Strategies to improve the outcome of advanced prostate cancer
ICM - Room 5
12:30(1h 30m)
The Hans Keulen Memorial Debate - Cancer heroes: Do they exist? And who are they?
Hall B4 - Room 24
08:00(1h)
Assessments and monitoring in advanced cancer nursing
16:30(1h 30m)
Awards and closing remarks
09:15(1h 30m)
Complex symptom burden and management related to multimodality cancer treatment
12:30(30m)
EONS Poster diplay
13:00(1h 30m)
Industry satellite symposium - EONS 9
14:45(1h 30m)
New cancer nursing roles: Innovation in action
11:00(1h 30m)
Nurse-led cancer services
ICM - Room 14c
18:30(1h 15m)
ESMO 2018 General Assembly
13:00(1h)
YO Clinical Case Discussion: Clinical Cases of Solid Tumours - Discussion Forum for Young Oncologists
09:30(1h)
YO Mentorship Session: Career paths in oncology
Hall A3 - Poster Area Networking Hub
12:45(1h)
Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events